Mehta Vimal
CIK 0001733369 Name as filed on the most recent filing
Filed as Mehta Vimal (19)
51 transaction lines · from 19 filings · filed 2018-11-30 to 2026-05-22 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
46 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2026-05-20 |
BioXcel Therapeutics, Inc. BTAI |
S, Open-market sale | 19,419 disposed | 1.09 | 21,108.45 | Form 4, filing 0001104659-26-065836 | |
| 2024-12-16 |
BioXcel Therapeutics, Inc. BTAI |
S, Open-market sale | 2,134 disposed | 0.36 | 773.36 | Form 4, filing 0001104659-24-129462 | |
| 2024-12-16 |
BioXcel Therapeutics, Inc. BTAI |
S, Open-market sale | 983 disposed | 0.36 | 357.91 | Form 4, filing 0001104659-24-129462 | |
| 2024-09-16 |
BioXcel Therapeutics, Inc. BTAI |
S, Open-market sale | 1,150 disposed | 0.69 | 794.08 | Form 4, filing 0001104659-24-100751 | |
| 2024-09-16 |
BioXcel Therapeutics, Inc. BTAI |
S, Open-market sale | 832 disposed | 0.69 | 572.83 | Form 4, filing 0001104659-24-100751 | |
| 2024-06-17 |
BioXcel Therapeutics, Inc. BTAI |
S, Open-market sale | 2,134 disposed | 1.28 | 2,738.99 | Form 4, filing 0001104659-24-072999 | |
| 2024-06-05 |
BioXcel Therapeutics, Inc. BTAI |
S, Open-market sale | 283,122 disposed | Not reported | Not priced | Form 4, filing 0001104659-24-069195 | |
| 2024-06-05 |
BioXcel Therapeutics, Inc. BTAI |
S, Open-market sale | 126,014 disposed | 1.58 | 199,618.78 | Form 4, filing 0001104659-24-069195 | |
| 2024-06-04 |
BioXcel Therapeutics, Inc. BTAI |
S, Open-market sale | 609,221 disposed | Not reported | Not priced | Form 4, filing 0001104659-24-069195 | |
| 2024-06-04 |
BioXcel Therapeutics, Inc. BTAI |
S, Open-market sale | 283,123 disposed | Not reported | Not priced | Form 4, filing 0001104659-24-069195 | |
| 2024-06-04 |
BioXcel Therapeutics, Inc. BTAI |
S, Open-market sale | 126,014 disposed | 1.63 | 205,516.23 | Form 4, filing 0001104659-24-069195 | |
| 2024-04-04 |
BioXcel Therapeutics, Inc. BTAI |
S, Open-market sale | 4,439 disposed | 2.62 | 11,651.04 | Form 4, filing 0001104659-24-044861 | |
| 2024-04-04 |
BioXcel Therapeutics, Inc. BTAI |
S, Open-market sale | 829 disposed | 2.62 | 2,171.98 | Form 4, filing 0001104659-24-044861 | |
| 2023-06-16 |
BioXcel Therapeutics, Inc. BTAI |
S, Open-market sale | 24,987 disposed | 20.01 | 499,989.87 | Form 4, filing 0001104659-23-072396 | |
| 2023-06-16 |
BioXcel Therapeutics, Inc. BTAI |
S, Open-market sale | 4,266 disposed | 20.90 | 89,159.40 | Form 4, filing 0001104659-23-072396 | |
| 2023-06-16 |
BioXcel Therapeutics, Inc. BTAI |
S, Open-market sale | 747 disposed | 21.89 | 16,351.83 | Form 4, filing 0001104659-23-072396 | |
| 2023-06-15 |
BioXcel Therapeutics, Inc. BTAI |
S, Open-market sale | 21,988 disposed | 21.41 | 470,763.08 | Form 4, filing 0001104659-23-072396 | |
| 2023-06-15 |
BioXcel Therapeutics, Inc. BTAI |
S, Open-market sale | 8,012 disposed | 21.90 | 175,462.80 | Form 4, filing 0001104659-23-072396 | |
| 2023-05-22 |
BioXcel Therapeutics, Inc. BTAI |
S, Open-market sale | 6,500 disposed | 25.79 | 167,640.85 | Form 4, filing 0001104659-23-064163 | |
| 2023-03-21 |
BioXcel Therapeutics, Inc. BTAI |
S, Open-market sale | 29,100 disposed | 19.70 | 573,270.00 | Form 4, filing 0001104659-23-035711 | |
| 2023-03-21 |
BioXcel Therapeutics, Inc. BTAI |
S, Open-market sale | 900 disposed | 20.15 | 18,135.00 | Form 4, filing 0001104659-23-035711 | |
| 2023-03-20 |
BioXcel Therapeutics, Inc. BTAI |
S, Open-market sale | 24,667 disposed | 18.20 | 448,939.40 | Form 4, filing 0001104659-23-035711 | |
| 2023-03-20 |
BioXcel Therapeutics, Inc. BTAI |
S, Open-market sale | 5,333 disposed | 18.86 | 100,580.38 | Form 4, filing 0001104659-23-035711 | |
| 2023-03-20 |
BioXcel Therapeutics, Inc. BTAI |
S, Open-market sale | 3,896 disposed | 18.22 | 70,985.12 | Form 4, filing 0001104659-23-035711 | |
| 2023-03-20 |
BioXcel Therapeutics, Inc. BTAI |
S, Open-market sale | 604 disposed | 18.88 | 11,403.52 | Form 4, filing 0001104659-23-035711 | |
| 2022-12-16 |
BioXcel Therapeutics, Inc. BTAI |
S, Open-market sale | 20,113 disposed | 19.21 | 386,370.73 | Form 4, filing 0001104659-22-128367 | |
| 2022-12-16 |
BioXcel Therapeutics, Inc. BTAI |
S, Open-market sale | 9,887 disposed | 19.92 | 196,949.04 | Form 4, filing 0001104659-22-128367 | |
| 2022-12-15 |
BioXcel Therapeutics, Inc. BTAI |
S, Open-market sale | 22,794 disposed | 19.86 | 452,688.84 | Form 4, filing 0001104659-22-128367 | |
| 2022-12-15 |
BioXcel Therapeutics, Inc. BTAI |
S, Open-market sale | 7,206 disposed | 20.19 | 145,489.14 | Form 4, filing 0001104659-22-128367 | |
| 2021-06-25 |
BioXcel Therapeutics, Inc. BTAI |
S, Open-market sale | 473,250 disposed | 30.83 | 14,589,492.98 | Form 4, filing 0001104659-21-086948 | |
| 2019-08-16 |
BioXcel Therapeutics, Inc. BTAI |
P, Open-market purchase | 974 acquired | 8.89 | 8,658.86 | Form 4, filing 0001104659-19-046520 | |
| 2019-08-15 |
BioXcel Therapeutics, Inc. BTAI |
P, Open-market purchase | 2,625 acquired | 8.67 | 22,758.75 | Form 4, filing 0001104659-19-046363 | |
| 2019-08-14 |
BioXcel Therapeutics, Inc. BTAI |
P, Open-market purchase | 358 acquired | 8.44 | 3,021.52 | Form 4, filing 0001104659-19-046363 | |
| 2019-08-13 |
BioXcel Therapeutics, Inc. BTAI |
P, Open-market purchase | 1,000 acquired | 8.75 | 8,750.00 | Form 4, filing 0001104659-19-045931 | |
| 2018-12-14 |
BioXcel Therapeutics, Inc. BTAI |
P, Open-market purchase | 800 acquired | 4.27 | 3,416.00 | Form 4, filing 0001104659-18-073106 | |
| 2018-12-14 |
BioXcel Therapeutics, Inc. BTAI |
P, Open-market purchase | 500 acquired | 4.48 | 2,240.00 | Form 4, filing 0001104659-18-073106 | |
| 2018-12-14 |
BioXcel Therapeutics, Inc. BTAI |
P, Open-market purchase | 400 acquired | 4.49 | 1,796.00 | Form 4, filing 0001104659-18-073106 | |
| 2018-12-14 |
BioXcel Therapeutics, Inc. BTAI |
P, Open-market purchase | 200 acquired | 4.32 | 864.00 | Form 4, filing 0001104659-18-073106 | |
| 2018-12-14 |
BioXcel Therapeutics, Inc. BTAI |
P, Open-market purchase | 100 acquired | 4.50 | 450.00 | Form 4, filing 0001104659-18-073106 | |
| 2018-12-04 |
BioXcel Therapeutics, Inc. BTAI |
P, Open-market purchase | 500 acquired | 5.15 | 2,575.00 | Form 4, filing 0001104659-18-071405 | |
| 2018-12-04 |
BioXcel Therapeutics, Inc. BTAI |
P, Open-market purchase | 500 acquired | 5.09 | 2,545.00 | Form 4, filing 0001104659-18-071405 | |
| 2018-12-03 |
BioXcel Therapeutics, Inc. BTAI |
P, Open-market purchase | 500 acquired | 5.20 | 2,600.00 | Form 4, filing 0001104659-18-071220 | |
| 2018-12-03 |
BioXcel Therapeutics, Inc. BTAI |
P, Open-market purchase | 200 acquired | 5.10 | 1,020.00 | Form 4, filing 0001104659-18-071220 | |
| 2018-12-03 |
BioXcel Therapeutics, Inc. BTAI |
P, Open-market purchase | 100 acquired | 5.18 | 518.00 | Form 4, filing 0001104659-18-071220 | |
| 2018-12-03 |
BioXcel Therapeutics, Inc. BTAI |
P, Open-market purchase | 100 acquired | 5.14 | 514.00 | Form 4, filing 0001104659-18-071220 | |
| 2018-12-03 |
BioXcel Therapeutics, Inc. BTAI |
P, Open-market purchase | 100 acquired | 5.13 | 513.00 | Form 4, filing 0001104659-18-071220 | |
| 2018-11-30 |
BioXcel Therapeutics, Inc. BTAI |
P, Open-market purchase | 300 acquired | 5.20 | 1,560.00 | Form 4, filing 0001104659-18-070826 | |
| 2018-11-30 |
BioXcel Therapeutics, Inc. BTAI |
P, Open-market purchase | 300 acquired | 5.05 | 1,515.00 | Form 4, filing 0001104659-18-070826 | |
| 2018-11-30 |
BioXcel Therapeutics, Inc. BTAI |
P, Open-market purchase | 300 acquired | 5.04 | 1,512.00 | Form 4, filing 0001104659-18-070826 | |
| 2018-11-30 |
BioXcel Therapeutics, Inc. BTAI |
P, Open-market purchase | 100 acquired | 5.17 | 517.00 | Form 4, filing 0001104659-18-070826 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- S, Open-market sale
- Open-market sale
- P, Open-market purchase
- Open-market purchase
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.
- Open-market purchase 21
- Open-market sale 25
- Option exercise 0
- Grant or award 0
- Tax withholding 0
- Disposition to the issuer 0
- In-the-money option exercise 0
How to cite this page
ebomi catalog. Mehta Vimal, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001733369
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6